Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Therapeutic effects of dietary intervention on neuroinflammation and brain metabolism in a rat model of photothrombotic stroke.

Kurtys E, Casteels C, Real CC, Eisel ULM, Verkuyl JM, Broersen LM, Klein HC, Dierckx RAJO, Doorduin J, de Vries EFJ.

CNS Neurosci Ther. 2018 May 27. doi: 10.1111/cns.12976. [Epub ahead of print]

PMID:
29804326
2.

Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study.

Koleva-Kolarova RG, Greuter MJW, Feenstra TL, Vermeulen KM, de Vries EFJ, Parkin D, Buskens E, de Bock GH.

Oncotarget. 2018 Apr 13;9(28):19836-19846. doi: 10.18632/oncotarget.24869. eCollection 2018 Apr 13.

3.

Unraveling the drivers of regional variation in healthcare spending by analyzing prevalent chronic diseases.

de Vries EF, Heijink R, Struijs JN, Baan CA.

BMC Health Serv Res. 2018 May 3;18(1):323. doi: 10.1186/s12913-018-3128-4.

4.

(18)F-fluoroestradiol Tumor Uptake is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients.

Nienhuis HH, van Kruchten M, Elias SG, Glaudemans AWJM, de Vries EFJ, Bongaerts AHH, Schröder CP, de Vries EGE, Hospers GAP.

J Nucl Med. 2018 Mar 30. pii: jnumed.117.198846. doi: 10.2967/jnumed.117.198846. [Epub ahead of print]

PMID:
29602822
5.

Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C]DASB Positron Emission Tomography Study.

Smit M, Vállez García D, de Jong BM, Zoons E, Booij J, Dierckx RA, Willemsen AT, de Vries EF, Bartels AL, Tijssen MA.

Front Neurol. 2018 Feb 28;9:88. doi: 10.3389/fneur.2018.00088. eCollection 2018.

6.

Anti-inflammatory effects of rice bran components.

Kurtys E, Eisel ULM, Hageman RJJ, Verkuyl JM, Broersen LM, Dierckx RAJO, de Vries EFJ.

Nutr Rev. 2018 May 1;76(5):372-379. doi: 10.1093/nutrit/nuy011.

PMID:
29534224
7.

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

Hartimath SV, Manuelli V, Zijlma R, Signore A, Nayak TK, Freimoser-Grundschober A, Klein C, Dierckx RAJO, de Vries EFJ.

Oncotarget. 2018 Jan 2;9(6):7162-7174. doi: 10.18632/oncotarget.23852. eCollection 2018 Jan 23.

8.

Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson's disease using [11C]PBR28 and [18F]FDOPA PET.

Real CC, Doorduin J, Kopschina Feltes P, Vállez García D, de Paula Faria D, Britto LR, de Vries EF.

J Cereb Blood Flow Metab. 2017 Dec 22:271678X17750351. doi: 10.1177/0271678X17750351. [Epub ahead of print]

PMID:
29271291
9.

Repeated social defeat induces transient glial activation and brain hypometabolism: A positron emission tomography imaging study.

Kopschina Feltes P, de Vries EF, Juarez-Orozco LE, Kurtys E, Dierckx RA, Moriguchi-Jeckel CM, Doorduin J.

J Cereb Blood Flow Metab. 2017 Jan 1:271678X17747189. doi: 10.1177/0271678X17747189. [Epub ahead of print]

PMID:
29271288
10.

The Role of PET in Monitoring Therapy in Fungal Infections.

Ankrah AO, Klein HC, Span LFR, de Vries EFJ, Dierckx RAJO, Sathekge MM, Glaudemans AWJM.

Curr Pharm Des. 2018;24(7):795-805. doi: 10.2174/1381612824666171213101648.

PMID:
29237376
11.

Sex steroid hormones and brain function: PET imaging as a tool for research.

Moraga-Amaro R, van Waarde A, Doorduin J, de Vries EFJ.

J Neuroendocrinol. 2018 Feb;30(2). doi: 10.1111/jne.12565. Review.

12.

PET Imaging with S-[11C]Methyl-L-Cysteine and L-[Methyl-11C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation.

Parente A, van Waarde A, Shoji A, de Paula Faria D, Maas B, Zijlma R, Dierckx RAJO, Langendijk JA, de Vries EFJ, Doorduin J.

Mol Imaging Biol. 2018 Jun;20(3):465-472. doi: 10.1007/s11307-017-1137-z.

13.

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.

Venema CM, Mammatas LH, Schröder CP, van Kruchten M, Apollonio G, Glaudemans AWJM, Bongaerts AHH, Hoekstra OS, Verheul HMW, Boven E, van der Vegt B, de Vries EFJ, de Vries EGE, Boellaard R, Menke van der Houven van Oordt CW, Hospers GAP.

J Nucl Med. 2017 Dec;58(12):1906-1912. doi: 10.2967/jnumed.117.193649. Epub 2017 Sep 14.

PMID:
28912144
14.

In Vivo Quantification of ERβ Expression by Pharmacokinetic Modeling: Studies with 18F-FHNP PET.

Antunes IF, Willemsen ATM, Sijbesma JWA, Boerema AS, van Waarde A, Glaudemans AWJM, Dierckx RAJO, de Vries EGE, Hospers GAP, de Vries EFJ.

J Nucl Med. 2017 Nov;58(11):1743-1748. doi: 10.2967/jnumed.117.192666. Epub 2017 Jul 13.

PMID:
28705918
15.

Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.

Kopschina Feltes P, Doorduin J, Klein HC, Juárez-Orozco LE, Dierckx RA, Moriguchi-Jeckel CM, de Vries EF.

J Psychopharmacol. 2017 Sep;31(9):1149-1165. doi: 10.1177/0269881117711708. Epub 2017 Jun 27. Review.

16.

Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.

Zhou X, Doorduin J, Elsinga PH, Dierckx RAJO, de Vries EFJ, Casteels C.

Neuroimage. 2017 Aug 15;157:209-218. doi: 10.1016/j.neuroimage.2017.05.066. Epub 2017 Jun 2.

PMID:
28583881
17.

Contribution of neuroinflammation to changes in [11C]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue.

Parente A, Vállez García D, Shoji A, Lopes Alves I, Maas B, Zijlma R, Dierckx RA, Buchpiguel CA, de Vries EF, Doorduin J.

Nucl Med Biol. 2017 Jun;49:50-56. doi: 10.1016/j.nucmedbio.2017.03.001. Epub 2017 Mar 18.

PMID:
28364664
18.

Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis.

Vállez García D, Doorduin J, de Paula Faria D, Dierckx RAJO, de Vries EFJ.

J Neuroimmune Pharmacol. 2017 Sep;12(3):521-530. doi: 10.1007/s11481-017-9741-x. Epub 2017 Mar 30.

19.

Human Epidermal Growth Factor Receptor 3-Specific Tumor Uptake and Biodistribution of 89Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging.

Warnders FJ, Terwisscha van Scheltinga AGT, Knuehl C, van Roy M, de Vries EFJ, Kosterink JGW, de Vries EGE, Lub-de Hooge MN.

J Nucl Med. 2017 Aug;58(8):1210-1215. doi: 10.2967/jnumed.116.181586. Epub 2017 Mar 30.

PMID:
28360206
20.

Initial Evaluation of an Adenosine A2A Receptor Ligand, 11C-Preladenant, in Healthy Human Subjects.

Sakata M, Ishibashi K, Imai M, Wagatsuma K, Ishii K, Zhou X, de Vries EFJ, Elsinga PH, Ishiwata K, Toyohara J.

J Nucl Med. 2017 Sep;58(9):1464-1470. doi: 10.2967/jnumed.116.188474. Epub 2017 Mar 9.

PMID:
28280214
21.

Noninvasive monitoring of cancer therapy induced activated T cells using [18F]FB-IL-2 PET imaging.

Hartimath SV, Draghiciu O, van de Wall S, Manuelli V, Dierckx RA, Nijman HW, Daemen T, de Vries EF.

Oncoimmunology. 2016 Nov 18;6(1):e1248014. doi: 10.1080/2162402X.2016.1248014. eCollection 2017.

22.

Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging.

van Waarde A, Dierckx RAJO, Zhou X, Khanapur S, Tsukada H, Ishiwata K, Luurtsema G, de Vries EFJ, Elsinga PH.

Med Res Rev. 2018 Jan;38(1):5-56. doi: 10.1002/med.21432. Epub 2017 Jan 27. Review.

PMID:
28128443
23.

In Vivo Evaluation of 11C-Preladenant for PET Imaging of Adenosine A2A Receptors in the Conscious Monkey.

Zhou X, Boellaard R, Ishiwata K, Sakata M, Dierckx RAJO, de Jong JR, Nishiyama S, Ohba H, Tsukada H, de Vries EFJ, Elsinga PH.

J Nucl Med. 2017 May;58(5):762-767. doi: 10.2967/jnumed.116.182410. Epub 2017 Jan 6.

24.

Improved GMP-compliant multi-dose production and quality control of 6-[18F]fluoro-L-DOPA.

Luurtsema G, Boersma HH, Schepers M, de Vries AMT, Maas B, Zijlma R, de Vries EFJ, Elsinga PH.

EJNMMI Radiopharm Chem. 2017;1(1):7. doi: 10.1186/s41181-016-0009-1. Epub 2016 Apr 4.

25.

Synthesis and Evaluation of the Estrogen Receptor β-Selective Radioligand 2-18F-Fluoro-6-(6-Hydroxynaphthalen-2-yl)Pyridin-3-ol: Comparison with 16α-18F-Fluoro-17β-Estradiol.

Antunes IF, van Waarde A, Dierckx RA, de Vries EG, Hospers GA, de Vries EF.

J Nucl Med. 2017 Apr;58(4):554-559. doi: 10.2967/jnumed.116.180158. Epub 2016 Dec 1.

26.

N-[11C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs.

Hartimath SV, Khayum MA, van Waarde A, Dierckx RAJO, de Vries EFJ.

Mol Imaging Biol. 2017 Aug;19(4):570-577. doi: 10.1007/s11307-016-1028-8.

27.

Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience.

Venema CM, Apollonio G, Hospers GA, Schröder CP, Dierckx RA, de Vries EF, Glaudemans AW.

Clin Nucl Med. 2016 Nov;41(11):844-851. Review.

PMID:
27607175
28.

Radiation Dosimetry of a Novel Adenosine A2A Receptor Radioligand [11C]Preladenant Based on PET/CT Imaging and Ex Vivo Biodistribution in Rats.

Zhou X, Elsinga PH, Khanapur S, Dierckx RA, de Vries EF, de Jong JR.

Mol Imaging Biol. 2017 Apr;19(2):289-297. doi: 10.1007/s11307-016-0992-3.

29.

Are low-value care measures up to the task? A systematic review of the literature.

de Vries EF, Struijs JN, Heijink R, Hendrikx RJ, Baan CA.

BMC Health Serv Res. 2016 Aug 18;16(1):405. doi: 10.1186/s12913-016-1656-3. Review.

30.

The combination of vitamins and omega-3 fatty acids has an enhanced anti-inflammatory effect on microglia.

Kurtys E, Eisel ULM, Verkuyl JM, Broersen LM, Dierckx RAJO, de Vries EFJ.

Neurochem Int. 2016 Oct;99:206-214. doi: 10.1016/j.neuint.2016.07.008. Epub 2016 Jul 25.

PMID:
27465516
31.

Evaluating [11C]PBR28 PET for Monitoring Gut and Brain Inflammation in a Rat Model of Chemically Induced Colitis.

Kurtys E, Doorduin J, Eisel UL, Dierckx RA, de Vries EF.

Mol Imaging Biol. 2017 Feb;19(1):68-76. doi: 10.1007/s11307-016-0979-0.

32.

Corrigendum to "Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study" [Brain Behav. Immun. (2015)].

Haarman BCM', Burger H, Doorduin J, Renken RJ, Sibeijn-Kuiper AJ, Marsman JC, de Vries EFJ, de Groot JC, Drexhage HA, Mendes R, Nolen WA, Riemersma-Van der Lek RF.

Brain Behav Immun. 2017 Mar;61:387-388. doi: 10.1016/j.bbi.2016.05.001. Epub 2016 Jun 13. No abstract available.

PMID:
27311765
33.

Modelling the Cost-Effectiveness of Delaying End-Stage Renal Disease.

de Vries EF, Rabelink TJ, van den Hout WB.

Nephron. 2016;133(2):89-97. doi: 10.1159/000446548. Epub 2016 Jun 8.

34.

PET/CT imaging of Mycobacterium tuberculosis infection.

Ankrah AO, van der Werf TS, de Vries EF, Dierckx RA, Sathekge MM, Glaudemans AW.

Clin Transl Imaging. 2016;4:131-144. Epub 2016 Mar 7. Review.

35.

Isolation and (111)In-Oxine Labeling of Murine NK Cells for Assessment of Cell Trafficking in Orthotopic Lung Tumor Model.

Malviya G, Nayak T, Gerdes C, Dierckx RA, Signore A, de Vries EF.

Mol Pharm. 2016 Apr 4;13(4):1329-38. doi: 10.1021/acs.molpharmaceut.5b00947. Epub 2016 Mar 24.

PMID:
26962716
36.

In vivo evaluation of [11C]preladenant positron emission tomography for quantification of adenosine A2A receptors in the rat brain.

Zhou X, Khanapur S, de Jong JR, Willemsen AT, Dierckx RA, Elsinga PH, de Vries EF.

J Cereb Blood Flow Metab. 2017 Feb;37(2):577-589. doi: 10.1177/0271678X16634714. Epub 2016 Jul 20.

37.

Pharmacokinetic Analysis of 11C-PBR28 in the Rat Model of Herpes Encephalitis: Comparison with (R)-11C-PK11195.

Parente A, Feltes PK, Vállez García D, Sijbesma JW, Moriguchi Jeckel CM, Dierckx RA, de Vries EF, Doorduin J.

J Nucl Med. 2016 May;57(5):785-91. doi: 10.2967/jnumed.115.165019. Epub 2016 Jan 28.

38.

Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study.

Haarman BC, Burger H, Doorduin J, Renken RJ, Sibeijn-Kuiper AJ, Marsman JB, de Vries EF, de Groot JC, Drexhage HA, Mendes R, Nolen WA, Riemersma-Van der Lek RF.

Brain Behav Immun. 2016 Aug;56:21-33. doi: 10.1016/j.bbi.2015.09.004. Epub 2015 Sep 5.

PMID:
26348581
39.

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy.

van Kruchten M, Glaudemans AWJM, de Vries EFJ, Schröder CP, de Vries EGE, Hospers GAP.

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1674-1681. doi: 10.1007/s00259-015-3107-5. Epub 2015 Jun 20.

40.

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.

Koleva-Kolarova RG, Greuter MJ, van Kruchten M, Vermeulen KM, Feenstra T, Buskens E, Glaudemans AW, de Vries EF, de Vries EG, Hospers GA, de Bock GH.

Br J Cancer. 2015 May 12;112(10):1617-25. doi: 10.1038/bjc.2015.138. Epub 2015 Apr 16.

41.

PET beyond ¹⁸F-FDG: second generation PET tracers in clinical oncology.

Brouwers AH, Glaudemans AW, De Vries EF.

Q J Nucl Med Mol Imaging. 2015 Mar;59(1):1-3. No abstract available.

PMID:
25854554
42.

Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis.

Vállez Garcia D, de Vries EF, Toyohara J, Ishiwata K, Hatano K, Dierckx RA, Doorduin J.

Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1106-18. doi: 10.1007/s00259-015-3021-x. Epub 2015 Mar 13.

43.

Breast cancer: a new imaging approach as an addition to existing guidelines.

Dorrius MD, de Vries EF, Slart RH, Glaudemans AW.

Eur J Nucl Med Mol Imaging. 2015 May;42(6):813-7. doi: 10.1007/s00259-015-3032-7. Epub 2015 Mar 12. No abstract available.

PMID:
25761830
44.

In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.

Khayum MA, Doorduin J, Antunes IF, Kwizera C, Zijlma R, den Boer JA, Dierckx RA, de Vries EF.

Nucl Med Biol. 2015 Jun;42(6):561-9. doi: 10.1016/j.nucmedbio.2015.02.003. Epub 2015 Feb 11.

45.

Dextrin-based nanomagnetogel: in vivo biodistribution and stability.

Gonçalves C, Silva JP, Antunes IF, Ferreira MF, Martins JA, Geraldes CF, Lalatonne Y, Motte L, de Vries EF, Gama FM.

Bioconjug Chem. 2015 Apr 15;26(4):699-706. doi: 10.1021/acs.bioconjchem.5b00024. Epub 2015 Mar 12.

PMID:
25734258
46.

Detection of intra-abdominal testicles with 16β-[(18)F]-fluoro-5α-dihydrotestosterone positron emission tomography/computed tomography in a pubertal boy.

Glaudemans AW, de Vries EF, Luurtsema G, Cornelissen EA, Feitz WF, Farinha Antunes I, Slart RH, Bongaerts AH, Kömhoff M.

J Pediatr. 2015 Mar;166(3):774-4.e1. doi: 10.1016/j.jpeds.2014.11.017. Epub 2014 Dec 30. No abstract available.

PMID:
25556018
47.

Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.

van Kruchten M, de Vries EF, Arts HJ, Jager NM, Bongaerts AH, Glaudemans AW, Hollema H, de Vries EG, Hospers GA, Reyners AK.

J Nucl Med. 2015 Jan;56(1):50-5. doi: 10.2967/jnumed.114.147579. Epub 2014 Dec 4.

48.

Measuring residual estrogen receptor availability during fulvestrant therapy in patients with metastatic breast cancer.

van Kruchten M, de Vries EG, Glaudemans AW, van Lanschot MC, van Faassen M, Kema IP, Brown M, Schröder CP, de Vries EF, Hospers GA.

Cancer Discov. 2015 Jan;5(1):72-81. doi: 10.1158/2159-8290.CD-14-0697. Epub 2014 Nov 7.

49.

Synthesis and preclinical evaluation of 2-(2-furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C]Preladenant) as a PET tracer for the imaging of cerebral adenosine A2A receptors.

Zhou X, Khanapur S, Huizing AP, Zijlma R, Schepers M, Dierckx RA, van Waarde A, de Vries EF, Elsinga PH.

J Med Chem. 2014 Nov 13;57(21):9204-10. doi: 10.1021/jm501065t. Epub 2014 Oct 15.

PMID:
25279444
50.

Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.

Hartimath SV, van Waarde A, Dierckx RA, de Vries EF.

Mol Pharm. 2014 Nov 3;11(11):3810-7. doi: 10.1021/mp500398r. Epub 2014 Aug 18.

PMID:
25094028

Supplemental Content

Loading ...
Support Center